Reversible effects of daclizumab HYP on lymphocyte counts in RRMS patients: Data from the select trilogy studies

Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: 284df99a0b2182f0d165b6ee82ebf6fe2bbc7a71
First added on: Feb 07, 2025